Patent 9505784 was granted and assigned to Dana-Farber Cancer Institute on November, 2016 by the United States Patent and Trademark Office.
The present application relates to therapeutic organic compounds, compositions comprising an effective amount of a therapeutic organic compound; and methods for treating and preventing disease comprising administering and effective amount of a therapeutic organic compound to a subject in need thereof.